On June 16 Stockholm Science City had a seminar focusing on Hagastaden and the possibilities the cluster brings for companies and organisations within life science.
– Hagastaden has all the important components of at successful life science cluster, including different healthcare providers, industry, universities, different investors, conference venues, hotels, cafes, restaurants and other services, says Filippa Kull, Business Development Director at Stockholm Science City, who introduced by giving an update about Hagastaden from the life science perspective.
You will also learn more from the experiences of Niclas Roxhed, associate professor at KTH and director of MedTechLabs, an interdisciplinary centre for medical technology research located in Hagastaden. Niclas is also affiliated with MIT in Boston, USA, and co-founder of several start-ups.
In the panel discussion we focused on Hagastaden and the possibilities the cluster brings for companies and organisations within life science, Niclas and Filippa will be joined by Jesper Ericsson, CEO of the Swedish biotech company Symcel, and Jenny Riazzoli, Therapeutic Area Lead, Respiratory & Immunology at AstraZeneca, who recently moved parts of their operations into new offices in Hagastaden.
- The reporten Life science i Stockholm-Uppsalaregionen (in Swedish) >>
- The report Life science in the Stockholm-Uppsala region (in English) >>
Watch the recorded seminar below.